Prognostic value of clinical markers of reperfusion in patients with acute myocardial infarction treated by thrombolytic therapy

scientific article

Prognostic value of clinical markers of reperfusion in patients with acute myocardial infarction treated by thrombolytic therapy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0002-8703(97)70045-0
P698PubMed publication ID9351729

P2093author name stringConti C
Ohman EM
Garber V
Calandrelli M
Grancelli H
Pomés Iparraguirre H
Volman S
P2860cites workAn international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigatorsQ28254763
Reduction in ST segment elevation after thrombolysis predicts either coronary reperfusion or preservation of left ventricular functionQ33610405
Rapid resolution of ST elevation and prediction of clinical outcome in patients undergoing thrombolysis with alteplase (recombinant tissue-type plasminogen activator): results of the Israeli Study of Early Intervention in Myocardial InfarctionQ33610600
Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I InvestigatorsQ34320363
Limitations of thrombolytic therapy for acute myocardial infarction complicated by congestive heart failure and cardiogenic shockQ37307302
ST segment changes as a surrogate end point in coronary thrombolysisQ37950269
A simple electrocardiographic predictor of the outcome of patients with acute myocardial infarction treated with a thrombolytic agent. A Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2)-Derived AnalysisQ39481678
Determinants of infarct size in reperfusion therapy for acute myocardial infarctionQ41113237
Decreased incidence of ventricular late potentials after successful thrombolytic therapy for acute myocardial infarctionQ43595052
Usefulness of a rapid initial increase in plasma creatine kinase activity as a marker of reperfusion during thrombolytic therapy for acute myocardial infarction.Q45994728
Open infarct artery, late potentials, and other prognostic factors in patients after acute myocardial infarction in the thrombolytic era. A prospective trial.Q54022853
Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patientsQ54066813
Angiographically assessed coronary arterial patency and reocclusion in patients with acute myocardial infarction treated with anistreplase: Results of the anistreplase reocclusion multicenter study (ARMS)Q54075661
Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. The Thrombolysis in Myocardial Infarction (TIMI) Phase II Co-InvestigatorsQ68860541
Ventricular arrhythmias initiated by programmed stimulation in four groups of patients with healed myocardial infarctionQ69621314
Prediction of infarct coronary artery recanalization after intravenous thrombolytic therapyQ69772573
Noninvasive detection of coronary artery patency using continuous ST-segment monitoringQ70040102
Factors that determine recovery of left ventricular function after thrombolysis in patients with acute myocardial infarctionQ70106634
Assessment of coronary artery patency after thrombolytic therapy: accurate prediction utilizing the combined analysis of three noninvasive markersQ70190040
The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trialQ70331348
Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysisQ70384839
Patency of the infarct-related artery and left ventricular function as the major determinants of survival after Q-wave acute myocardial infarctionQ70529543
Intravenous streptokinase in evolving acute myocardial infarctionQ71315607
Noninvasive detection of reperfusion after thrombolysis based on serum creatine kinase MB changes and clinical variables. TAMI 7 Study Group. Thrombolysis and Angioplasty in Myocardial InfarctionQ72541009
The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarctionQ72585330
Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarctionQ72708498
Continuous 12-lead ST-segment recovery analysis in the TAMI 7 study. Performance of a noninvasive method for real-time detection of failed myocardial reperfusionQ72852230
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectthrombolysisQ1931577
acute myocardial infarctionQ18558122
P304page(s)631-638
P577publication date1997-10-01
P1433published inAmerican Heart JournalQ2227156
P1476titlePrognostic value of clinical markers of reperfusion in patients with acute myocardial infarction treated by thrombolytic therapy
P478volume134